<?xml version="1.0" encoding="UTF-8"?>
<results title="tropicalVirus">
 <result pre="Reporter MR766-Based Flow Cytometry Neutralization Test for Rapid Detection of" exact="Zika" post="Virus-Neutralizing Antibodies in Serum Specimens https://orcid.org/0000-0002-7734-7737FrumenceEtiennehttps://orcid.org/0000-0002-0915-8635ViranaickenWildrisshttps://orcid.org/0000-0001-6325-4866GadeaGilleshttps://orcid.org/0000-0001-8926-4050DesprèsPhilippe*[], *Correspondence: philippe.despres@univ-reunion.fr; Tel.:"/>
 <result pre="of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Abstract" exact="Zika" post="virus (ZIKV) is an emerging arthropod-borne virus of major"/>
 <result pre="is an emerging arthropod-borne virus of major public health concern." exact="ZIKV" post="infection is responsible for congenital Zika disease and other"/>
 <result pre="major public health concern. ZIKV infection is responsible for congenital" exact="Zika" post="disease and other neurological defects. Antibody-mediated virus neutralization is"/>
 <result pre="In the present study, we assessed whether our GFP reporter" exact="ZIKV" post="derived from African viral strain MR766 could be useful"/>
 <result pre="immune sera from adult mice that received ZIKBeHMR-2. The chimeric" exact="ZIKV" post="clone ZIKBeHMR-2 comprises the structural protein region of epidemic"/>
 <result pre="valid format for measuring ZIKV-neutralizing antibodies in serum specimens. arbovirus" exact="Zika" post="virus GFP reporter ZIKV flow cytometry neutralization test mouse"/>
 <result pre="ZIKV-neutralizing antibodies in serum specimens. arbovirus Zika virus GFP reporter" exact="ZIKV" post="flow cytometry neutralization test mouse immune sera humoral immune"/>
 <result pre="plaque-reduction neutralization test flow cytometry neutralization test 1. Introduction Mosquito-borne" exact="Zika" post="virus (ZIKV) is an emerging flavivirus initially reported in"/>
 <result pre="emerging flavivirus initially reported in Africa in 1947 [1]. Recently," exact="ZIKV" post="became a public health concern with recent epidemics occurring"/>
 <result pre="Polynesia (2013), and South America (2015) [2]. During these outbreaks," exact="ZIKV" post="infection was reported to cause severe complications in humans,"/>
 <result pre="abnormalities in infants and Guillain-Barre syndrome in adults [3]. Also," exact="ZIKV" post="is capable of long-term persistence in human body fluids"/>
 <result pre="transmission of disease has been documented [4,5]. Laboratory diagnosis of" exact="ZIKV" post="infection is mainly based on RT-PCR method during the"/>
 <result pre="the acute phase of the disease [5,6,7,8]. Serological diagnosis of" exact="ZIKV" post="infection is obtained at least one week after the"/>
 <result pre="antigenic cross-reactivity making inconclusive serological tests especially in regions where" exact="ZIKV" post="and related flaviviruses, such as dengue viruses, co-circulate. To"/>
 <result pre="issue, the detection of antibodies that have neutralizing activity against" exact="ZIKV" post="can be achieved to confirm recent infection [8]. Plaque-reduction"/>
 <result pre="gene-based methods for neutralizing assays have been recently developed for" exact="ZIKV" post="[10,11,12]. Given that reporter systems afford the ability to"/>
 <result pre="expression inside the infected cells, we generated a GFP reporter" exact="ZIKV" post="entitled ZIKVGFP [13]. We demonstrated that ZIKVGFP is a"/>
 <result pre="that ZIKVGFP is a performing tool for the monitoring of" exact="ZIKV" post="replication in the host cell as well as the"/>
 <result pre="Biotech, Aidenbach, Germany). The recombinant ZIKVGFP derived from molecular clone" exact="ZIKV" post="MR766MC is described elsewhere [13]. ZIKVGFP and derived viral"/>
 <result pre="Cytometry Neutralization Test To generate a more reliable GFP reporter" exact="ZIKV" post="for flow cytometry neutralization test, recombinant ZIKVGFP was repeatedly"/>
 <result pre="1B). Thus, the MR766GFP variant is a suitable GFP reporter" exact="ZIKV" post="for the development of a FNT. 3.2. Comparison Between"/>
 <result pre="adult mice that received intraperitoneally 5 log PFU of chimeric" exact="ZIKV" post="clone ZIKBeHMR-2 developed high titers of ZIKV-neutralizing antibodies [23]."/>
 <result pre="of ZIKV-neutralizing antibodies [23]. ZIKBeHMR-2 is a chimeric clone of" exact="ZIKV" post="derived from historical African ZIKV strain MR766 in which"/>
 <result pre="is a chimeric clone of ZIKV derived from historical African" exact="ZIKV" post="strain MR766 in which the structural protein region was"/>
 <result pre="the structural protein region was replaced with that of epidemic" exact="ZIKV" post="strain BeH819015 of Asian lineage [23]. Noteworthy, the ZIKBeHMR-2"/>
 <result pre="aim, we took advantage of our previously developed GFP reporter" exact="ZIKV" post="(recombinant ZIKVGFP), which had been demonstrated to be a"/>
 <result pre="ZIKBeHMR-2, which contains the structural protein region of epidemic Brazilian" exact="ZIKV" post="strain BeH810915 into a MR766 backbone [23]. ZIKBeHMR-2 has"/>
 <result pre="in 96-well-plates. The neutralizing activity of anti-ZIKBeHMR-2 immune sera against" exact="ZIKV" post="was estimated within two days. There was a linear"/>
 <result pre="is a suitable method for the general measurement of antibody-mediated" exact="ZIKV" post="neutralization. Now, it is of paramount importance to estimate"/>
 <result pre="the detection of ZIKV-neutralizing antibodies using human serum specimens from" exact="Zika" post="patients. 5. Conclusions In the present study, we demonstrated"/>
 <result pre="demonstrated that viral clone MR766GFP is a suitable GFP reporter" exact="ZIKV" post="for the identification of ZIKV-neutralizing antibodies in serum specimens"/>
 <result pre="could provide a reliable platform for measuring antibodies that neutralize" exact="ZIKV" post="in a large number of serum specimens without the"/>
 <result pre="in the patent entitled &quot;Vaccine compositions comprising an attenuated mutant" exact="Zika" post="virus�? under the number WO2017220748A1 (priority date 2016-06-23). Acknowledgments"/>
 <result pre="the AmericasJ. Gen. Virol.20169726927310.1099/jgv.0.00038126684466 3.Cao-LormeauV.M.BlakeA.MonsS.LastereS.RocheC.VanhomwegenJ.DubT.BaudouinL.TeissierA.LarreP.et al.Guillain-Barré Syndrome outbreak associated with" exact="Zika" post="virus infection in French Polynesia: A case-control studyLancet20163871531153910.1016/S0140-6736(16)00562-626948433 4.Runge-RanzingerS.MorrisonA.C.Manrique-SaideP.HorstickO.Zika"/>
 <result pre="Health20192452352910.1111/tmi.1321630771269 5.MussoD.GublerD.J.Zika VirusClin. Microbiol. Rev.20162948752410.1128/CMR.00072-1527029595 6.LanciottiR.S.KosoyO.L.LavenJ.J.VelezJ.O.LambertA.J.JohnsonA.J.StanfieldS.M.DuffyM.R.Genetic and serologic properties of" exact="Zika" post="virus associated with an epidemic, Yap State, Micronesia, 2007Emerg."/>
 <result pre="J.2013195334010.1016/j.tvjl.2012.08.01923036176 9.RoehrigJ.T.HombachJ.BarrettA.D.T.Guidelines for Plaque-Reduction Neutralization Testing of Human Antibodies to" exact="Dengue" post="VirusesViral Immunol.20082112313210.1089/vim.2008.000718476771 10.MatsudaM.YamanakaA.YatoK.YoshiiK.WatashiK.AizakiH.KonishiE.TakasakiT.KatoT.MuramatsuM.et al.High-throughput neutralization assay for multiple flaviviruses"/>
 <result pre="using dengue virus type 1 reporter repliconSci. Rep.2018810.1038/s41598-018-34865-y 11.ShanC.XieX.RenP.LoeffelholzM.J.YangY.FuruyaA.DupuisA.P.KramerL.D.WongS.J.ShiP.-Y.A Rapid" exact="Zika" post="Diagnostic Assay to Measure Neutralizing Antibodies in PatientsEBioMedicine20171715716210.1016/j.ebiom.2017.03.00628283425 12.KoishiA.C.SuzukawaA.A.ZanlucaC.CamachoD.E.ComachG.Duarte"/>
 <result pre="a novel high-throughput image-based fluorescent neutralization test for detection of" exact="Zika" post="virus infectionPLoS Negl. Trop. Dis.201812e000634210.1371/journal.pntd.000634229543803 13.GadeaG.BosS.Krejbich-TrototP.ClainE.ViranaickenW.El-KalamouniC.MavinguiP.DesprèsP.A robust method for"/>
 <result pre="Dis.201812e000634210.1371/journal.pntd.000634229543803 13.GadeaG.BosS.Krejbich-TrototP.ClainE.ViranaickenW.El-KalamouniC.MavinguiP.DesprèsP.A robust method for the rapid generation of recombinant" exact="Zika" post="virus expressing the GFP reporter geneVirology201649715716210.1016/j.virol.2016.07.01527471954 14.El KalamouniC.FrumenceE.BosS.TurpinJ.NativelB.HarrabiW.WilkinsonD.A.MeilhacO.GadeaG.DesprèsP.et al.Subversion"/>
 <result pre="14.El KalamouniC.FrumenceE.BosS.TurpinJ.NativelB.HarrabiW.WilkinsonD.A.MeilhacO.GadeaG.DesprèsP.et al.Subversion of the Heme Oxygenase-1 Antiviral Activity by" exact="Zika" post="VirusViruses201811210.3390/v1101000230577437 15.ClainE.SinigagliaL.KoishiA.C.GorgetteO.GadeaG.ViranaickenW.Krejbich-TrototP.MavinguiP.DesprèsP.Nunes Duarte Dos SantosC.et al.Extract from Aphloia theiformis,"/>
 <result pre="Aphloia theiformis, an edible indigenous plant from Reunion Island, impairs" exact="Zika" post="virus attachment to the host cell surfaceSci. Rep.201881085610.1038/s41598-018-29183-230022045 16.HaddadJ.G.KoishiA.C.GaudryA.Nunes"/>
 <result pre="Medicinal Plant from Mascarene Islands, Is a Potent Inhibitor of" exact="Zika" post="and Dengue Virus Infection in Human CellsInt. J. Mol."/>
 <result pre="from Mascarene Islands, Is a Potent Inhibitor of Zika and" exact="Dengue" post="Virus Infection in Human CellsInt. J. Mol. Sci.201920232810.3390/ijms2010238231091703 17.ClainE.HaddadJ.G.KoishiA.C.SinigagliaL.RachidiW.DesprèsP.Duarte"/>
 <result pre="Medicinal Plant from Reunion Island, Inhibits the Early Stages of" exact="Dengue" post="and Zika Virus InfectionInt. J. Mol. Sci.201920186010.3390/ijms2008186030991717 18.GaudryA.BosS.ViranaickenW.RocheM.Krejbich-TrototP.GadeaG.DesprèsP.El-KalamouniC.The Flavonoid"/>
 <result pre="from Reunion Island, Inhibits the Early Stages of Dengue and" exact="Zika" post="Virus InfectionInt. J. Mol. Sci.201920186010.3390/ijms2008186030991717 18.GaudryA.BosS.ViranaickenW.RocheM.Krejbich-TrototP.GadeaG.DesprèsP.El-KalamouniC.The Flavonoid Isoquercitrin Precludes"/>
 <result pre="InfectionInt. J. Mol. Sci.201920186010.3390/ijms2008186030991717 18.GaudryA.BosS.ViranaickenW.RocheM.Krejbich-TrototP.GadeaG.DesprèsP.El-KalamouniC.The Flavonoid Isoquercitrin Precludes Initiation of" exact="Zika" post="Virus Infection in Human CellsInt. J. Mol. Sci.201819109310.3390/ijms19041093 19.VanwalscappelB.GadeaG.DesprèsP.A"/>
 <result pre="Virus ActivityInt. J. Mol. Sci.201920157410.3390/ijms20071574 20.VanwalscappelB.TadaT.LandauN.R.Toll-like receptor agonist R848 blocks" exact="Zika" post="virus replication by inducing the antiviral protein viperinVirology201852219920810.1016/j.virol.2018.07.01430036788 21.FrumenceE.RocheM.Krejbich-TrototP.El-KalamouniC.NativelB.RondeauP.MisséD.GadeaG.ViranaickenW.DesprèsP.The"/>
 <result pre="the antiviral protein viperinVirology201852219920810.1016/j.virol.2018.07.01430036788 21.FrumenceE.RocheM.Krejbich-TrototP.El-KalamouniC.NativelB.RondeauP.MisséD.GadeaG.ViranaickenW.DesprèsP.The South Pacific epidemic strain of" exact="Zika" post="virus replicates efficiently in human epithelial A549 cells leading"/>
 <result pre="Guidelines for planning animal research and testingLab. Anim.20185213514110.1177/002367721772482328771074 23.FrumenceE.ViranaickenW.BosS.Alvarez-MartinezM.-T.RocheM.ArnaudJ.-D.GadeaG.DesprèsP.A Chimeric" exact="Zika" post="Virus between Viral Strains MR766 and BeH819015 Highlights a"/>
 <result pre="Vero cells. The neutralizing ability of mouse serum specimens against" exact="ZIKV" post="was determined by flow cytometry neutralization test (FNT) on"/>
 <result pre="A549 cells. The neutralizing ability of mouse serum specimens against" exact="ZIKV" post="was determined by FNT on A549 cells. Samples of"/>
</results>
